Texas Hemp Rules Set to Take Effect March 31, Laredo Smoke Shops Brace for Impact
Texas hemp rules are set to take effect on March 31, impacting the availability of smokable hemp-derived THC products. Laredo smoke shops are preparing for significant changes due to these new regulations. Clinicians should understand these rules to…
Vaping Linked to Faster Onset of Cannabis Disorder: Study Insights
A recent study highlights vaping cannabis disorder leads to a faster onset of dependence than other methods. Vaped cannabis reaches the brain more rapidly, increasing addiction risk. Clinicians should counsel patients on vaping cannabis disorder risks…
No ‘Next Day’ Impairment Caused by Cannabis – The Leaf Online
Recent research on no next day cannabis impairment offers new clinical insights. This focus keyword highlights findings about cannabis timing and safety. Understanding cannabis effects on daytime function is crucial for patient counseling.
Arizona Officials Recall Marijuana Preroll Due to Fungal Contamination
Arizona health officials issued a recall due to fungal contamination cannabis risks in marijuana prerolls. This highlights serious safety concerns for immunocompromised patients. Clinicians should counsel patients on these risks and verify product safety.
Lawmakers Send Right to Try Medical Cannabis Act, Ibogaine Trials to Governor
The Right to Try Medical Cannabis Act expands patient access to cannabis outside standard trials. This legislation allows compassionate use for serious conditions. Clinicians must understand this act to guide patients on safety and legal issues.
Avicanna Sponsors University of Calgary’s ‘Sensitive Dosing Window’ Medical THC Study
The sensitive dosing window medical THC study provides crucial evidence-based guidance for clinicians prescribing medical cannabis. This University of Calgary research identifies effective THC dosing ranges that improve patient outcomes. Findings support…
Study Finds Little Proof Cannabis Helps Most Mental Health Conditions
This study examines cannabis effectiveness mental health and finds limited proof supporting its use for most psychiatric conditions. Despite patient interest, clinical evidence remains insufficient. Clinicians should prioritize evidence-based treatments…
Cannabis useless for treating mental health issues – Australian review – Juta MedicalBrief
The Australian review highlights cannabis mental health clinical evidence as insufficient for treating depression, anxiety, and psychosis. This challenges common patient beliefs about cannabis benefits for psychiatric conditions. Clinicians should guide…
New trial suggests CBD oil could lower anxiety in autistic children and reduce parenting stress
A new trial suggests cbd oil anxiety autistic children may reduce anxiety symptoms and parenting stress. This preliminary evidence supports cbd oil as a potential therapeutic option. Clinicians should await further research before widespread…
Large Medical Cannabis Review Finds Scarce Evidence It Treats Mental Health Disorders
A large review finds scarce evidence supporting cannabis mental health disorders efficacy. Clinicians face uncertainty due to limited data on cannabis mental health disorders efficacy and safety. Patients should be counseled on established treatments…